Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ – STARS Reports
$115.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Mindray Medical International Ltd reaffirms FY 2014 guidance


Monday, 5 May 2014 05:00pm EDT 

Mindray Medical International Ltd:Continues to expect FY 2014 net revenues to grow at least 15pct over its FY 2013 net revenues.Continues to anticipate FY 2014 non-GAAP net income to remain at a similar level to FY 2013 non-GAAP net income.Reported revenue of $1.2 billion and net income of $224.8 million in FY 2013.FY 2014 revenue of $1.4 billion and net income of $240 million - Thomson Reuters I/B/E/S. 

Company Quote

32.06
-0.01 -0.03%
10:43am EDT